These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
489 related items for PubMed ID: 25617029
1. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Nadel J, Lancefield T, Voskoboinik A, Taylor AJ. Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):634-41. PubMed ID: 25617029 [Abstract] [Full Text] [Related]
2. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675 [Abstract] [Full Text] [Related]
3. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Flamée L, Symons R, Degtiarova G, Dresselaers T, Gheysens O, Wuyts W, Van Cleemput J, Bogaert J. Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494 [Abstract] [Full Text] [Related]
4. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Cain MA, Metzl MD, Patel AR, Addetia K, Spencer KT, Sweiss NJ, Beshai JF. Am J Cardiol; 2014 May 01; 113(9):1556-60. PubMed ID: 24731652 [Abstract] [Full Text] [Related]
7. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Agoston-Coldea L, Kouaho S, Sacre K, Dossier A, Escoubet B, Chillon S, Laissy JP, Rouzet F, Kutty S, Extramiana F, Leenhardt A, Borie R, Crestani B, Ou P. Int J Cardiol; 2016 Nov 01; 222():950-956. PubMed ID: 27526366 [Abstract] [Full Text] [Related]
8. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. Coleman GC, Shaw PW, Balfour PC, Gonzalez JA, Kramer CM, Patel AR, Salerno M. JACC Cardiovasc Imaging; 2017 Apr 01; 10(4):411-420. PubMed ID: 27450877 [Abstract] [Full Text] [Related]
11. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K. Chest; 2014 Oct 01; 146(4):1064-1072. PubMed ID: 24853830 [Abstract] [Full Text] [Related]
12. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy. Klopotowski M, Kukula K, Malek LA, Spiewak M, Polanska-Skrzypczyk M, Jamiolkowski J, Dabrowski M, Baranowski R, Klisiewicz A, Kusmierczyk M, Jasinska A, Jarmus E, Kruk M, Ruzyllo W, Witkowski A, Chojnowska L. J Cardiol; 2016 Jul 01; 68(1):49-56. PubMed ID: 26363820 [Abstract] [Full Text] [Related]
20. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis. Stanton KM, Ganigara M, Corte P, Celermajer DS, McGuire MA, Torzillo PJ, Corte TJ, Puranik R. Heart Lung Circ; 2017 Nov 01; 26(11):1191-1199. PubMed ID: 28501519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]